109 related articles for article (PubMed ID: 6764105)
1. [Chemotherapy of hormone-unresponsive prostatic cancer and its metastatic foci].
Kotake T
Gan To Kagaku Ryoho; 1982 Mar; 9(3):387-96. PubMed ID: 6764105
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of hormonally unresponsive prostatic carcinoma.
deKernion JB; Lindner A
Urol Clin North Am; 1984 May; 11(2):319-26. PubMed ID: 6233779
[TBL] [Abstract][Full Text] [Related]
3. The chemotherapy of prostatic carcinoma.
Beckley S; Wajsman Z; Slack N; Mittelman A; Murphy GP
Scand J Urol Nephrol Suppl; 1980; 55():151-62. PubMed ID: 6938019
[TBL] [Abstract][Full Text] [Related]
4. [Treatment for hormone-refractory or relapsing prostatic cancer].
Hirao Y; Ozono S; Okajima E
Gan To Kagaku Ryoho; 1996 Mar; 23(4):418-26. PubMed ID: 8678492
[TBL] [Abstract][Full Text] [Related]
5. Results of trials of the USA National Prostatic Cancer Project.
Elder JS; Gibbons RP
Prog Clin Biol Res; 1985; 185A():221-42. PubMed ID: 3898131
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy of prostatic carcinoma].
Wirth M; Altwein JE
Urologe A; 1991 Jan; 30(1):17-24. PubMed ID: 2014582
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of advanced prostatic carcinoma with cis-diamminedichloroplatinum].
Okumura S; Hasegawa J; Ohhara M; Kawamura N; Abe H; Yui Y; Kanamori S; Yoshida K; Nishimura T; Tomita M
Hinyokika Kiyo; 1984 Dec; 30(12):1801-7. PubMed ID: 6543417
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy: is it effective in treatment of prostatic cancer?
Murphy GP
Urology; 1984 Nov; 24(5 Suppl):41-7. PubMed ID: 6388094
[TBL] [Abstract][Full Text] [Related]
9. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy of prostatic cancer.
Schmidt JD
Urol Clin North Am; 1975 Feb; 2(1):185-96. PubMed ID: 1093059
[TBL] [Abstract][Full Text] [Related]
11. National randomized study of chemotherapeutic agents in advanced prostatic carcinoma: a progress report.
Johnson DE; Scott WW; Gibbons RP; Prout GR; Schmidt JD; Chu TM; Gaeta J; Saroff J; Murphy GP
Cancer Treat Rep; 1977; 61(2):317-23. PubMed ID: 141326
[TBL] [Abstract][Full Text] [Related]
12. [Cytostatic therapy of prostatic carcinoma. Current status and personal results].
Nagel R; Leistenschneider W
Urologe A; 1983 Sep; 22 Suppl():304-9. PubMed ID: 6356555
[TBL] [Abstract][Full Text] [Related]
13. Current treatment of advanced prostate cancer.
Ismail M; Gomella LG
Tech Urol; 1997; 3(1):16-24. PubMed ID: 9170220
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for non-hormone refractory prostate cancer.
Winquist E
Can J Urol; 2006 Feb; 13 Suppl 1():67-70. PubMed ID: 16526986
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy in cancer of the prostate].
D'Acremont B; Gattegno B; Cohen L; Fiatte P; Lucaks B; Thibault P
Ann Urol (Paris); 1990; 24(2):87-95. PubMed ID: 2190532
[TBL] [Abstract][Full Text] [Related]
16. Management of hormone refractory prostate cancer: current standards and future prospects.
Oh WK; Kantoff PW
J Urol; 1998 Oct; 160(4):1220-9. PubMed ID: 9751323
[TBL] [Abstract][Full Text] [Related]
17. The case for early chemotherapy for the treatment of metastatic disease.
Lucas A; Petrylak DP
J Urol; 2006 Dec; 176(6 Pt 2):S72-5. PubMed ID: 17084173
[TBL] [Abstract][Full Text] [Related]
18. The role of systemic cytotoxic therapy for prostate cancer.
Chang SS; Kibel AS
BJU Int; 2009 Jan; 103(1):8-17. PubMed ID: 19040524
[TBL] [Abstract][Full Text] [Related]
19. Second-line chemotherapy for advanced hormone-refractory prostate cancer.
Garmey EG; Sartor O; Halabi S; Vogelzang NJ
Clin Adv Hematol Oncol; 2008 Feb; 6(2):118-22, 127-32. PubMed ID: 18347563
[TBL] [Abstract][Full Text] [Related]
20. Treatment options in androgen-independent prostate cancer.
Lara PN; Meyers FJ
Cancer Invest; 1999; 17(2):137-44. PubMed ID: 10071598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
